Skip to main content
OpenTrials
Completed

NCT Number: NCT03640702

The Effect of Primary Cesarean Section Prevention on Maternal and Neonatal Outcomes

The study aimed to examine the effect of prolonging the second stage of labor on the rate of Cesarean section (CS), maternal and neonatal outcomes.

The study compared 2 time periods. The first time period was between May 2011 until April 2014 when a prolonged second stage in nulliparous women was considered three hours with regional anesthesia or two hours if no such anesthesia was provided. Second stage arrest was defined in multiparous women after two hours with regional anesthesia or one hour without it. The second time period was between May 2014 until April 2017, allowed nulliparous and multiparous women to continue the second stage of labor an additional one hour before diagnosing second-stage arrest. Singleton deliveries at or beyond 37 weeks' gestation were initially considered for eligibility.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Observational

Primary location

Rambam Health Care Campus

Haifa, Israel

About this study

The study aimed to examine the effect of prolonging the second stage of labor on the rate of Cesarean section (CS), maternal and neonatal outcomes.

The study compared 2 time periods. The first time period was between May 2011 until April 2014 when a prolonged second stage in nulliparous women was considered three hours with regional anesthesia or two hours if no such anesthesia was provided. Second stage arrest was defined in multiparous women after two hours with regional anesthesia or one hour without it. The second time period was between May 2014 until April 2017, allowed nulliparous and multiparous women to continue the second stage of labor an additional one hour before diagnosing second-stage arrest. Singleton deliveries at or beyond 37 weeks' gestation were initially considered for eligibility.

The rate of CS, operative vaginal deliveries, 3rd and 4th degree lacerations, postpartum hemorrhage, arterial cord PH below 7 and admissions to the neonatal intensive care unit (NICU).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Singleton deliveries at or beyond 37 weeks' gestation.

Exclusion criteria

  • Non-vertex presentation.
  • Trial of labor after CS.
  • High risk pregnancy (multiple gestation, preeclampsia, diabetes mellitus, intrauterine growth restriction).
  • Known fetal anomalies and intrauterine fetal demise.

Treatment and study plan

Protocol change

Other

To examine the effect of prolonging the second stage of labor on the rate of cesarean delivery, maternal and neonatal outcomes

Primary outcomes

  1. The rate of primary CS.

    Time frame: Between 2011 and 2017.

    The rate of primary CS in percentage of the total participants.

Secondary outcomes

  1. The rate of operative vaginal delivery.

    Time frame: Between 2011 and 2017.

    The rate of operative vaginal delivery in percentage of the total participants.

  2. Post-partum hemorrhage.

    Time frame: Between 2011 and 2017.

    Post-partum hemorrhage as estimated in liters.

  3. The need for blood transfusion.

    Time frame: Between 2011 and 2017.

    Number and type of blood products required post-partum and calculation of the number of patients that required blood products out of the total number of participants in percentage.

  4. Third-and fourth-degree laceration rate.

    Time frame: Between 2011 and 2017.

    Third-and fourth-degree laceration rate of the total number of participants.

  5. Chorioamnionitis rate.

    Time frame: Between 2011 and 2017.

    Chorioamnionitis rate in percentage of the total participants.

  6. Admission to the NICU.

    Time frame: Between 2011 and 2017.

    Admission to the NICU in percentage of the total participants.

Sponsors and collaborators

Lead sponsor

Rambam Health Care Campus

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Aug 21, 2018
Registry last updated
Aug 21, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.